Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors
October 15, 2026 — Helus Pharma appoints Dr. Suresh Durgam to board, bolstering CNS pipeline. Learn how his FDA approval expertise supports late-stage development of NSAs for depression and anxiety.